17
Jan
2010
Keraderm Corp.: Series A $2.5M
Posted in I - Series A, Q - 4Q09, R - SOUTH EAST, X - Device (Phototherapy), XX - VA
Kerederm (Blacksburg, VA) a development-stage medical device company focused on the use of germicidal phototherapy to prevent and treat skin and nail infections, closed a $2.5M Series A financing. Participants include NewVa Capital Partners.
Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb.
OnBioVC PARTNERS
-
Where is OnBioVC Content Consumed?
